Pay in 4 interest-free payments of $6.05 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
In human clinical use, reported side effects are generally mild and transient: Mild injection site redness or discomfort (resolves within hours) Transient nausea in some patients, particularly early in the protocol Mild dizziness or light-headedness (rare, typically dose-related) Temporary fatigue in the first few days (often a sign of active tissue remodeling) No significant systemic toxicity, organ damage, hormonal suppression, or addiction potential has been documented in the published literature
Semaglutide users commonly report nausea (2030%) and constipation as digestion slows, while tirzepatides GIP activity may trigger more frequent diarrhea (1525%)
Thng tin dinh dng Khu phn: 2 vin
We conducted a subgroup analysis based on age to assess the proportional imbalance of AEs related to suicide/self-injury for GLP-1RA within different age groups
